Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

Clinical trial NCT05412290 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05412290
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma Aggressive Lymphoma Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Transformed Lymphoma Follicular Lymphoma Grade 3

Start date: 2022-12-22
Primary completion: 2027-01-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.